Tril - TLR4 interactor with leucine-rich repeats

Predicted to enable lipopolysaccharide binding activity. Predicted to be involved in regulation of cytokine production involved in immune response and toll-like receptor 4 signaling pathway. Predicted to act upstream of or within inflammatory response and innate immune response. Predicted to be located in membrane. Predicted to be integral component of membrane. Predicted to be part of lipopolysaccharide receptor complex. Predicted to be active in extracellular matrix and extracellular space. Orthologous to human TRIL (TLR4 interactor with leucine rich repeats). [provided by Alliance of Genome Resources, Apr 2022]